Diabetes is on the rise in children and young people

Published Date: 10 Mar 2023

New findings from researchers at Wake Forest University School of Medicine show that the rate of type 1 and type 2 diabetes is increasing...

Read Full News

Latest News

Trump Pricing Policy Will Affect Obesity Drug Launch in Europe

Eli Lilly expects to launch its weight-loss pill in Europe and Britain in the second half of ⁠2026 or early 2027, with the drugmaker targeting the out-of-pocket telehealth market.

GLP-1 QOL Benefits Greatest for Those With Obesity Plus T2D

Patients with co-occurring obesity and T2D have more favorable QOL outcomes on GLP-1s than those with either condition alone or multiple comorbidities.

Mediterranean Diet May Reduce Postpartum Metabolic Risk

A Mediterranean-based nutritional intervention initiated at 8-12 gestational weeks is associated with a reduced risk for metabolic syndrome 6 years postpartum, a prospective follow-up study finds.

China Approval for Eli Lilly GLP-1 Pill to Come as Soon as 2026, Executive Says

Eli Lilly's orforglipron type-2 diabetes and obesity pill could launch in China as soon ⁠as later this year, an executive at the U.S. drugmaker told Reuters, as rival Novo...

Urogenital Infections Tied to SGLT2 Therapy Discontinuation

Patients with type 2 diabetes who start SGLT2 inhibitors and then develop a urinary or genital tract infection are more likely to discontinue treatment than matched patients without an infection.

Protein Source Key for Weight Loss After Menopause

Postmenopausal women are often encouraged to eat more protein, but a new study finds that protein source matters, with plant-based protein outperforming animal protein for weight loss.

Todays Updates

Europe Must Rethink Medicine Pricing or Risk Losing Investment

Europe will need to rethink how it values and pays for innovative ⁠medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.

Medicare AI Creates Errors and Delays for Patients, Doctors

Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.

Is Creatine for Brain Health Worth a Try?

Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.

S1 Episode 2: Is Alcohol the Missing Piece in Your MASLD Workup?

Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera share practical tools to quantify intake, spot MetALD, and counsel patients effectively.

S1 Episode 1: Can Primary Care Catch MASLD Before Cirrhosis?

MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.

Palbociclib Gains HER2+ Breast Cancer Maintenance Indication

Palbociclib is now the first CDK4/6 inhibitor approved for metastatic disease regardless of HER2 status.

Mirvetuximab Fails to Boost Survival in Platinum-Eligible OC

Mirvetuximab has come up short in the first randomized trial testing an antibody-drug conjugate plus standard carboplatin for patients with platinum-sensitive ovarian cancer.

Todays Updates

Europe Must Rethink Medicine Pricing or Risk Losing Investment

Europe will need to rethink how it values and pays for innovative ⁠medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.

Medicare AI Creates Errors and Delays for Patients, Doctors

Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.

Is Creatine for Brain Health Worth a Try?

Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.

S1 Episode 2: Is Alcohol the Missing Piece in Your MASLD Workup?

Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera share practical tools to quantify intake, spot MetALD, and counsel patients effectively.

S1 Episode 1: Can Primary Care Catch MASLD Before Cirrhosis?

MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.

Palbociclib Gains HER2+ Breast Cancer Maintenance Indication

Palbociclib is now the first CDK4/6 inhibitor approved for metastatic disease regardless of HER2 status.

Mirvetuximab Fails to Boost Survival in Platinum-Eligible OC

Mirvetuximab has come up short in the first randomized trial testing an antibody-drug conjugate plus standard carboplatin for patients with platinum-sensitive ovarian cancer.

Latest News

Eli Lilly expects to launch its weight-loss pill in Europe and Britain in the second half of ⁠2026 or early 2027, with the drugmaker targeting the out-of-pocket telehealth market.

Patients with co-occurring obesity and T2D have more favorable QOL outcomes on GLP-1s than those with either condition alone or multiple comorbidities.

A Mediterranean-based nutritional intervention initiated at 8-12 gestational weeks is associated with a reduced risk for metabolic syndrome 6 years postpartum, a prospective follow-up study finds.

Eli Lilly's orforglipron type-2 diabetes and obesity pill could launch in China as soon ⁠as later this year, an executive at the U.S. drugmaker told Reuters, as rival Novo...

Patients with type 2 diabetes who start SGLT2 inhibitors and then develop a urinary or genital tract infection are more likely to discontinue treatment than matched patients without an infection.

Postmenopausal women are often encouraged to eat more protein, but a new study finds that protein source matters, with plant-based protein outperforming animal protein for weight loss.

News All Time

The HPV Vaccine at 20: Progress Made, Challenges Ahead

Evidence supports HPV vaccination as a powerful cancer prevention tool, but improving its uptake remains critical for achieving long-term public health goals.

Breast Cancer Patients Taking GLP-1s Had Better Survival

The findings from a large observational study underscore the need for randomized clinical trials to assess the relationship between GLP-1 use and outcomes in patients with cancer.

MRI Predicts Survival Better Than Pathology in Rectal Cancer

MRI provides a more reliable preoperative prediction of survival and recurrence in patients with rectal tumour than traditional histopathology.

Early Use Of Novocure's Brain Cancer Therapy Shows no Significant Survival Benefit in Late-stage Trial

Novocure said on Thursday that a late-stage trial showed early use of its non-invasive cancer therapy ⁠did not significantly improve overall survival in patients with newly...

Tirzepatide Tops Semaglutide in Real-World Weight Loss

Tirzepatide leads to greater and faster weight loss than semaglutide in a real-world analysis of more than 20,000 patients with obesity.

Medicine Shortages Among Worst Ever Seen, Pharmacists Warn

Health leaders are calling for an emergency taskforce as record-breaking shortages hit patients and stretch pharmacies to the limit.

GLP-1s Could Help Improve Symptoms of PMOS

The metabolic symptoms of PMOS, including overweight and diabetes, may be effectively treated by GLP-1s.

Are GLP-1s Increasing Eating Disorder Risk?

With GLP-1s readily available, some experts fear misuse is increasing and may be fueling eating disorders. Physicians describe what they are seeing and how they manage the risks.

US FDA Sends 25 Letters to Telehealth Companies Over Claims on Compounded Weight-loss Drugs

The U.S. Food and Drug Administration issued 25 warning letters to telehealth companies for marketing false and misleading claims about ⁠compounded versions of Eli Lilly and...

Sitting Less, More Light Activity May Reduce Pregnancy Risks

Pregnant individuals who sit for more than 10 hours daily face higher risks for adverse pregnancy outcomes, whereas about 7 hours of light-intensity activity daily is linked to a lower risk.

Support Groups Boost Weight Loss in Patients With Obesity

Consistent engagement in a support group paired with lifestyle changes has been shown to be linked to notably greater weight loss in a community gastroenterology clinic weight-management program.

GLP-1s Tied to Lower Cancer Risk in Patients With Obesity

In a large observational study of adults with obesity without diabetes, GLP-1 receptor agonists were associated with a 41% lower incidence of obesity-associated cancers over 2 years.

German Government to Abandon Variable Drug Discounting Plans, Source Tells Reuters

Germany's government is replacing plans that would have introduced variable discounts on pharmaceuticals, ⁠a government source told Reuters on Monday, following opposition...

Male Fertility Not Harmed by GLP-1s and Maybe Helped

A systematic review finds no consistent adverse effects on the male hypothalamic-pituitary-gonadal axis and some evidence of fertility improvement with GLP-1 use.

Tirzepatide May Reverse Postbariatric Weight Regain

Tirzepatide treatment yields substantial weight loss and is well tolerated in patients with recurrent weight gain after bariatric procedures, a small real-world observational study finds.

Distinct Courses in Primary and Secondary Empty Sella

Patients with primary and secondary empty sella show distinct clinical and endocrine trajectories over a median follow-up of about 5 years.

Recommended News For You

AI tool automates liver tumor detection and monitoring

New methods show how fast breast cancers grow and how surgery delays affect cancer staging

Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

Independent Risk Factors for "Deaths of Despair" Found.

Alone for 500 Days, but Never Lonely: The Introvert's Dream.

Reduced Suicide Rates in Cancer Patients; Enhanced Circadian Rhythm; HIV Vaccine for Cancer Patients?

Never in a million years did I think I'd have to limit my chemotherapy.

Recommended Articles For You

Progressive Updates in Oncology for Healthcare Excellence 

Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers 

From Birthmarks to Tumors: The Science Behind Infantile Hemangioma  

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

2.

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

3.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

4.

Microplastics can cause malignant changes in lung cells

5.

Higher Binge Drinking Rates Linked to New Cannabis Laws.

1.

A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia

2.

The Benefits and Risks of Cervical Conization

3.

What is Mullerian and How Does it Affect Your Health

4.

Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care

5.

Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

2.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

3.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

4.

Navigating the Complexities of Ph Negative ALL - Part XIII

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot